Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Elevation Oncology, Inc. - Common stock (NQ:ELEV)

0.3539 -0.0064 (-1.78%)
Streaming Delayed Price Updated: 2:41 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 295,941
Open 0.3582
Bid (Size) 0.3539 (2)
Ask (Size) 0.3558 (3)
Prev. Close 0.3603
Today's Range 0.3500 - 0.3700
52wk Range 0.2210 - 4.330
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Curious about the stocks that are showing activity after the closing bell on Monday?
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
Tesla To $410? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga

Performance

YTD
-40.5%
-40.5%
1 Month
+20.5%
+20.5%
3 Month
-43.2%
-43.2%
6 Month
-47.2%
-47.2%
1 Year
-90.0%
-90.0%

More News

Read More
Here are the top movers in Thursday's session.
Via Chartmill
Top movers in Thursday's session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Which stocks are gapping on Thursday?
Via Chartmill
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase
Via Benzinga
Exposures Fossil Fuels
Elevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70%
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise
Via Benzinga
This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Why Is Penny Stock Elevation Oncology Trading Lower On Tuesday?
Via Benzinga
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Dow Jumps Over 300 Points; US Trade Gap Narrows In June
Via Benzinga
Topics Stocks
Exposures US Equities
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
Via Benzinga
7 Top Stocks to Buy for Under $10: May 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
ELEV Stock Earnings: Elevation Oncology Misses EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
7 Top Stocks Under $7
Via InvestorPlace
5 Healthcare Stocks to Buy for 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence

Frequently Asked Questions

Is Elevation Oncology, Inc. - Common stock publicly traded?
Yes, Elevation Oncology, Inc. - Common stock is publicly traded.
What exchange does Elevation Oncology, Inc. - Common stock trade on?
Elevation Oncology, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Elevation Oncology, Inc. - Common stock?
The ticker symbol for Elevation Oncology, Inc. - Common stock is ELEV on the Nasdaq Stock Market
What is the current price of Elevation Oncology, Inc. - Common stock?
The current price of Elevation Oncology, Inc. - Common stock is 0.3539
When was Elevation Oncology, Inc. - Common stock last traded?
The last trade of Elevation Oncology, Inc. - Common stock was at 05/13/25 02:41 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.